To submit a grant posting, please fill out our web form or download the form
so that you can email us at grants@alzforum.org.
List the sponsor name, amount, due date, and contact information. This is a free service.
Please Note: We remove grant postings after 6 months. If you would like your listing to be posted longer or taken down sooner,
please contact us at grants@alzforum.org.
Sponsor: The Chan Zuckerberg Biohub Network and the Stellar Science Foundation
Award: The Global Science Scholars program is a postdoctoral fellowship of up to two years to conduct research in a world-class lab in Japan or the U.S. Researchers who have earned a doctoral degree on or after July 1, 2021 and are interested in pursuing interdisciplinary research at the forefront of biology and technology are encouraged to apply.
Due Date: Applications are accepted on a rolling basis and will be reviewed at several points during the open application period that runs until May 27, 2025. All awards may be allocated before the close of the application period on May 27, 2025. Once all fellowships are allocated, the application portal will close, and no further applications will be accepted. The program reserves the right to stop accepting applications at any time.
Sponsor: The NOMIS Foundation and Science magazine (AAAS)
Award: Two Grand Prize winners will each be awarded a cash prize of US $15,000 and provided travel and accommodation to the award ceremony, if applicable. Additionally, both Grand Prize winners will be invited to present a proposal for funding to the NOMIS foundation. Each winner will receive a 5-year digital subscription to Science and have their winning essays published in Science.
Due Date: May 15, 2025.
Sponsor: American Federation for Aging Research (AFAR)
Award: Each scholarship is $5,000. No indirect costs or overhead are allowed.
Due Date: April 15, 2025.
Sponsor: National Institute on Aging
Due Date: Multiple due dates; see announcement.
Sponsor: National Institute on Aging
Due Date: Multiple due dates; see announcement.
Sponsor: National Institute on Aging
Award: Submit applications for this initiative using one of the following notices of funding opportunities (NOFOs) or any reissues of these announcements through the expiration date of this notice:
PAR-25-331 - Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R21 Clinical Trial Not Allowed);
PAR-25-332 - Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R01 Clinical Trial Optional)
Due Date: This notice applies to due dates on or after March 11, 2025 and subsequent receipt dates through November 17, 2027.
Sponsor: National Institute on Aging
Award: Submit applications for this initiative using one of the following notices of funding opportunities (NOFOs) or any reissues of these announcements through the expiration date of this notice:
PAR-25-331 - Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R21 Clinical Trial Optional);
PAR-25-332 - Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R01 Clinical Trial Optional).
Due Date: This notice applies to due dates on or after March 11, 2025 and subsequent receipt dates through November 17, 2027.
Sponsor: National Institute on Aging
Award: Submit applications for this initiative using one of the following notices of funding opportunities (NOFOs) or any reissues of these announcements through the expiration date of this notice:
PAR-25-331 - Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R21 Clinical Trial Optional);
PAR-25-332 - Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R01 Clinical Trial Optional).
Due Date: This notice applies to due dates on or after March 11, 2025 and subsequent receipt dates through November 17, 2027.
Sponsor: National Institute of Neurological Disorders and Stroke
Due Date: Multiple due dates; see announcement.
Sponsor: National Institutes of Health
Due Date: Multiple due dates; see announcement.
Sponsor: National Institute on Aging
Award: Submit applications for this initiative using one of the following notices of funding opportunities (NOFOs) or any reissues of these announcements through the expiration date of this notice:
PAR-25-331 - Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R21 Clinical Trial Optional);
PAR-25-332 - Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R01 Clinical Trial Optional)
Due Date: This notice applies to due dates on or after March 11, 2025 and subsequent receipt dates through November 17, 2027.
Sponsor: National Institute on Aging
Award: Submit applications for this initiative using one of the following notice of funding opportunity (NOFO) or any reissues of these announcements through the expiration date of this notice:
PAR-25-331 - Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R21 Clinical Trial Optional); PAR-25-332 - Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R01 Clinical Trial Optional)
Due Date: This notice applies to due dates on or after March 11, 2025 and subsequent receipt dates through November 17, 2027.
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS), National Institute of Mental Health (NIMH)
Award: Direct costs are limited to $275,000 over a two-year period, with no more than $200,000 in direct costs allowed in any single year.
Due Date: Multiple due dates; see announcement.
Sponsor: National Institutes of Health
Award: Application budgets may not exceed $400,000 direct costs over a maximum three-year funding period. No more than $200,000 direct costs may be requested in any single year.
Due Date: Multiple due dates; see announcement.
Sponsor: National Institute on Aging
Award: Submit applications for this initiative using one of the following notices of funding opportunities (NOFOs) or any reissues of these announcements through the expiration date of this notice:
PAR-25-331 - Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R21 Clinical Trial Optional);
PAR-25-332 - Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R01 Clinical Trial Optional)
Due Date: This notice applies to due dates on or after March 11, 2025 and subsequent receipt dates through November 17, 2027 .
